⌘K

Home/Filings/4/0001469709-13-000122

4//SEC Filing

ANDRES DEVIN D. 4

Accession 0001469709-13-000122

CIK 0001408299other

View on SEC.gov Company Profile

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 5:18 PM ET

Size

5.3 KB

Accession

0001469709-13-000122

Insider Transaction Report

Form 4

Period: 2013-02-20

Entia Biosciences, Inc.ERGO

ANDRES DEVIN D.

Vice President Sales Marketing

Transactions

Award
Non-Statutory Stock Option
2013-02-20$0.38/sh+25,000$9,500→ 25,000 total
Exercise: $0.38From: 2013-02-20Exp: 2018-02-19→ Common Stock (25,000 underlying)

Documents

1 file

4
ergo-andres_form4022213apg.xmlPrimary
FORM 4 OWNERSHIP DOCUMENT

Issuer

Entia Biosciences, Inc.

CIK 0001408299

Entity typeother

Related Parties

1

filerCIK 0001504752

Filing Metadata

Form type: 4
Filed: Feb 21, 7:00 PM ET
Accepted: Feb 22, 5:18 PM ET
Size: 5.3 KB

View on SEC.gov